Humana Stock Price, News & Analysis

The Foundation for Social Connection and Humana will host Conversations on Belonging, Connection, & Wellbeing during Global Loneliness Awareness Week (June 13-17). Scheduled for June 15 at the U.S. Capitol Visitors Center, the event features U.S. Surgeon General Vivek Murthy and Jenna Bush Hager. The initiative addresses the rising issue of loneliness, emphasizing its health impacts and promoting social connection. Humana aims to elevate awareness through its "Far From Alone" campaign, collaborating with industry leaders to foster belonging and improve mental health.

Humana Inc. (NYSE: HUM) has announced the expansion of its rebranding initiative for the home health division of Kindred at Home (KAH), now transitioning to CenterWell Home Health. This Phase 2 addition includes 14 new states, bringing the total to 21 states involved in the transition. The initiative follows Humana's acquisition of KAH in August 2021 and aims to enhance home-based healthcare services. Phase 3 is set for early September, with operations in an additional 17 states expected to transition, ultimately covering over 350 locations across 38 states.

Humana Inc. (NYSE: HUM) announced that CFO Susan M. Diamond will present at the Jefferies Healthcare Conference on June 8, 2022, at 11:30 a.m. Eastern time. A live audio webcast will be available on Humana's Investor Relations page, with participants advised to log in 15 minutes early for system checks. Humana is dedicated to enhancing health outcomes through integrated care and support for healthcare professionals, focusing on Medicare members and various communities. For more information, visit humana.com.

Humana Inc. (NYSE: HUM) has partnered with Welsh, Carson, Anderson & Stowe to establish a new joint venture, allocating up to $1.2 billion to open 100 Medicare-focused primary care clinics by 2025. This follows a previous $800 million investment for 67 clinics by early 2023. The expansion will solidify Humana's status as the leading provider of senior-focused primary care nationally. While the new JV is expected to have an immaterial impact on Humana's earnings in 2022, it aims to enhance access to value-based care for Medicare patients.

Humana Specialty Pharmacy has been awarded the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the fifth consecutive year, highlighting its strong commitment to customer satisfaction and patient care. The award reflects the dedication of its staff, including pharmacists and care coordinators, in providing personalized care. Humana Specialty Pharmacy offers 24-hour access to pharmacists and supports patients applying for assistance programs for specialty drugs. Humana Inc. (NYSE: HUM) aims to improve health outcomes for its members through integrated care solutions.

Humana Inc. (NYSE: HUM) announced that CFO Susan M. Diamond will present at the BofA Securities Healthcare Conference on May 10, 2022, at 9:20 a.m. Pacific time. A live audio webcast will be accessible through Humana’s Investor Relations page, with participants encouraged to log in 15 minutes early for setup. Humana focuses on integrated care to improve health outcomes and lower costs for members, offering services in in-home care, behavioral health, and more. Additional information is available at humana.com.

Humana reported strong 1Q22 earnings with a GAAP EPS of $7.29 and an Adjusted EPS of $8.04, both exceeding previous year figures. The company raised FY 2022 EPS guidance to approximately $22.98 on a GAAP basis and $24.50 on an Adjusted basis, reflecting a 19% growth from FY 2021, despite a COVID-19 headwind. Humana anticipates membership growth of 150,000 to 200,000 in Medicare Advantage for FY 2022 and has introduced a $1 billion value creation initiative to enhance services. Total revenues rose to $23.97 billion from $20.67 billion year-over-year.

Humana Inc. has entered into a definitive agreement to divest a 60% interest in its Hospice and Personal Care divisions of Kindred at Home to Clayton, Dubilier & Rice for approximately $2.8 billion. This transaction reflects a valuation of $3.4 billion and a multiple of about 12 times the divisions’ forecasted Adjusted EBITDA. The move aligns with Humana's strategy to offload non-core segments while still maintaining a minority interest. Proceeds will be used for debt repayment and share repurchases, with no significant impact on 2022 earnings expected.

Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, payable on July 29, 2022, to stockholders of record as of June 30, 2022. This dividend reflects the company's commitment to providing value to its shareholders while maintaining a robust financial position. Humana focuses on integrated care solutions aimed at improving health outcomes and lowering costs for its members, contributing to a better quality of life for various communities.